Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Total Current Liabilities (2016 - 2026)

Champions Oncology has reported Total Current Liabilities over the past 16 years, most recently at $20.7 million for Q1 2026.

  • Quarterly results put Total Current Liabilities at $20.7 million for Q1 2026, up 4.06% from a year ago — trailing twelve months through Jan 2026 was $20.7 million (up 4.06% YoY), and the annual figure for FY2025 was $23.9 million, up 10.73%.
  • Total Current Liabilities for Q1 2026 was $20.7 million at Champions Oncology, down from $22.1 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for CSBR hit a ceiling of $23.9 million in Q2 2025 and a floor of $15.5 million in Q1 2022.
  • Median Total Current Liabilities over the past 5 years was $20.7 million (2026), compared with a mean of $20.2 million.
  • Biggest five-year swings in Total Current Liabilities: soared 56.08% in 2022 and later dropped 9.97% in 2024.
  • Champions Oncology's Total Current Liabilities stood at $18.7 million in 2022, then rose by 11.82% to $21.0 million in 2023, then dropped by 9.97% to $18.9 million in 2024, then rose by 17.39% to $22.1 million in 2025, then fell by 6.61% to $20.7 million in 2026.
  • The last three reported values for Total Current Liabilities were $20.7 million (Q1 2026), $22.1 million (Q4 2025), and $22.7 million (Q3 2025) per Business Quant data.